S49 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Supernus Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 40.6 EUR

Market Cap: €2.2B

S	Supernus Pharmaceuticals Inc F:S49	US
E	Exelon Corp XMUN:PEO	US
E	Exelon Corp BMV:EXC	US
	Asahi Kasei Corp F:ASA	JP
G	G-III Apparel Group Ltd SWB:GI4	US

Profitability Summary

Supernus Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

88%

Strong 3Y Average Gross Margin

89%

Gross Margin is Increasing

85% > 88%

Negative Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

3% > 0%

Negative Net Margin

-13%

Low 3Y Average Net Margin

Declining Net Margin

7% > -13%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

17%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

88%

Strong 3Y Average Gross Margin

89%

Gross Margin is Increasing

85% > 88%

Negative Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

3% > 0%

Negative Net Margin

-13%